Met decoys
- 1 July 2004
- journal article
- preview
- Published by Elsevier in Cancer Cell
- Vol. 6 (1), 5-6
- https://doi.org/10.1016/j.ccr.2004.07.003
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The Sema domain of Met is necessary for receptor dimerization and activationCancer Cell, 2004
- Targeting the tumor and its microenvironment by a dual-function decoy Met receptorCancer Cell, 2004
- Met, metastasis, motility and moreNature Reviews Molecular Cell Biology, 2003
- Scatter-factor and semaphorin receptors: cell signalling for invasive growthNature Reviews Cancer, 2002
- In vivo targeting of SF/HGF and c‐met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosisThe FASEB Journal, 2001
- Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinaseProceedings of the National Academy of Sciences, 2001
- Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal modelsProceedings of the National Academy of Sciences, 2001
- Potent Blockade of Hepatocyte Growth Factor-stimulated Cell Motility, Matrix Invasion and Branching Morphogenesis by Antagonists of Grb2 Src Homology 2 Domain InteractionsJournal of Biological Chemistry, 2001
- Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factorOncogene, 1998